# Impact of COX2 on Sera Biomarkers From Obese Subjects

> **NCT02062255** · EARLY_PHASE1 · COMPLETED · sponsor: **The University of Texas Health Science Center at San Antonio** · enrollment: 126 (actual)

## Conditions studied

- Breast Cancer Survivors

## Interventions

- **DRUG:** Aspirin
- **DIETARY_SUPPLEMENT:** Omega 3 FFA

## Key facts

- **NCT ID:** NCT02062255
- **Lead sponsor:** The University of Texas Health Science Center at San Antonio
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2016-04
- **Final completion:** 2016-04
- **Target enrollment:** 126 (ACTUAL)
- **Last updated:** 2016-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02062255

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02062255, "Impact of COX2 on Sera Biomarkers From Obese Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02062255. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*